S. 1302, titled the "Increasing Transparency in Generic Drug Applications Act," aims to make the process of applying for generic drug approval more transparent. The bill amends section 505(j)(3) of the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health...
Simple Explanation
S. 1302 is a bill that wants to make it clearer how companies get permission to sell copies of medicines. It asks for information about what is inside these new medicines, so people know if they are the same as the originals.